TipRanks
Go Ultimate55% OFF

Enlivex (1BT) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
AllocetraPrimary Knee OsteoarthritisPhase IIRecruitingIntra-Articular Allocetra in Patients With Primary Knee OsteoarthritisApr 23, 2026―
AllocetraArthritis, PsoriaticPhase IRecruitingEvaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic ArthritisJul 07, 2024
AllocetraOsteoarthritis, Kneephase1AndPhase2Active Not RecruitingStudy of Intra-articular Allocetra in Knee OsteoarthritisJan 22, 2024―
Allocetra-OtsUrinary Tract Infections, Sepsis, Community-Acquired Pneumonia, Cholecystitis, Acute, Cholangitis Acute, Intraabdominal InfectionsPhase IICompletedA Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis PatientsOct 26, 2020―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Enlivex Therapeutics (DE:1BT) have in its pipeline
Enlivex DE:1BT is currently developing the following drugs: Allocetra, Allocetra-Ots. These drug candidates are in various stages of clinical development as the company works toward FDA approval.